The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic modification of T cells with a novel bispecific chimeric antigen receptor to enhance the control of high-grade glioma (HGG).
Meenakshi Hegde
No relevant relationships to disclose
Amanda Wakefield
No relevant relationships to disclose
Vita S Brawley
No relevant relationships to disclose
Zakaria Grada
No relevant relationships to disclose
Tiara T Byrd
No relevant relationships to disclose
Kevin K Chow
No relevant relationships to disclose
Simone S Krebs
No relevant relationships to disclose
Helen E Heslop
Consultant or Advisory Role - Celgene; Cell Medica
Other Remuneration - Cell Medica
Stephen M Gottschalk
Consultant or Advisory Role - Bluebird Bio; Celgene
Other Remuneration - Cell Medica
Eric Yvon
No relevant relationships to disclose
Nabil Ahmed
Consultant or Advisory Role - Celgene